This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Committee for the Purpose of Control and Supervision of Experiments on Animals | |
|---|---|
| Name | Committee for the Purpose of Control and Supervision of Experiments on Animals |
| Abbreviation | CPCSEA |
| Formation | 1964 (statutory recognition 1998) |
| Headquarters | New Delhi |
| Region served | India |
| Parent organization | Department of Animal Husbandry and Dairying |
Committee for the Purpose of Control and Supervision of Experiments on Animals
The Committee for the Purpose of Control and Supervision of Experiments on Animals is an Indian statutory advisory and regulatory body overseeing animal use in scientific, educational, pharmaceutical, and industrial testing. It issues protocols, accredits institutional oversight, and interfaces with ministries, national laboratories, university campuses, veterinary institutions, and international standards bodies. The committee’s remit intersects with public policy, biomedical research, pharmaceutical regulation, and animal welfare advocacy.
The committee traces administrative origins to recommendations that followed discussions among actors such as the Indian Council of Medical Research, the Indian Veterinary Research Institute, and the University Grants Commission during the mid-20th century. Influential events shaping its trajectory included legislative debates in the Parliament of India and policy shifts under ministries including the Ministry of Agriculture and the Ministry of Health and Family Welfare. Judicial pronouncements by the Supreme Court of India and rulings influenced by petitions from organizations like the Animal Welfare Board of India and the People for Animals network accelerated statutory recognition. Engagements with international actors including the World Health Organization, the Council for International Organizations of Medical Sciences, and the International Council for Laboratory Animal Science informed procedural reforms and capacity building.
The committee operates under a statutory framework embedded in Indian law and administrative orders issued by the Department of Animal Husbandry and Dairying. Its mandate aligns with provisions that coordinate with statutes such as the Prevention of Cruelty to Animals Act and regulatory regimes administered by the Central Drugs Standard Control Organization and the Ministry of Environment, Forest and Climate Change. The committee’s charter defines responsibilities related to ethics review, approval of animal use protocols, accreditation of Institutional Animal Ethics Committees, and maintenance of breeding and housing standards that harmonize with international guidance from organizations like the Organisation for Economic Co-operation and Development and the European Medicines Agency.
Membership models combine ex officio officials, nominated scientists, veterinary specialists, and representatives of civil society. Typical seats are drawn from institutions such as the Indian Council of Agricultural Research, the Indian Council of Medical Research, the National Institute of Virology, and major universities like the All India Institute of Medical Sciences and Jawaharlal Nehru University. The committee’s secretariat is housed within administrative apparatuses in New Delhi and collaborates with state-level animal welfare bodies, university ethics committees, and research councils. Appointments historically involve nominations from ministries, professional associations like the Veterinary Council of India, and NGOs including the Federation of Indian Animal Protection Organisations.
The committee issues guidelines for ethical review, adjudicates complaints, and sets standards for housing, breeding, transport, and experimental procedures for species ranging from mice and rats to rabbits and non-human primates. It conducts capacity-building workshops with institutions such as the Indian Institutes of Technology, the National Centre for Biological Sciences, and pharmaceutical companies regulated by Cipla and Dr. Reddy’s Laboratories. The committee evaluates proposals linked to vaccines, diagnostics, and toxicity testing for entities including serum institutes, public health laboratories, and academic research groups. It also liaises with enforcement agencies and courts when investigative findings intersect with criminal or administrative actions.
The committee promulgates technical documents and schedules governing anesthesia, humane endpoints, and environmental enrichment compatible with standards from the World Organisation for Animal Health and the National Institutes of Health. It prescribes requirements for Institutional Animal Ethics Committees modeled after committees at organizations such as the Indian Statistical Institute and Tata Institute of Fundamental Research. Protocol templates, breeding registration norms, and records standards are designed to align with pharmacopoeial testing requirements used by the Central Drugs Standard Control Organization and submission dossiers prepared for regulatory authorities.
Enforcement mechanisms rely on inspections, show-cause notices, suspension of approvals, and coordination with police or judicial authorities where warranted. Inspection teams often include officials with backgrounds at the National Institute of Nutrition, state animal husbandry departments, and veterinary schools. The committee’s compliance actions have affected operations at private contract research organisations, university laboratories, and industrial testing facilities. Data reporting requirements and follow-up audits seek alignment with audit practices at institutions such as the Indian Audits and Accounts Service and standards invoked by accreditation agencies.
The committee has faced criticism from animal protection organizations including People for Animals, Humane Society International, and the Federation of Indian Animal Protection Organisations for perceived gaps in transparency, enforcement consistency, and record accessibility. Academic researchers and biotechnology firms have raised concerns about administrative delays affecting clinical development timelines at companies like Biocon and Bharat Biotech. Debates have emerged regarding the use of non-human primates, outsourcing of toxicity studies to contract research organisations, and harmonization with international 3Rs (replacement, reduction, refinement) recommendations advanced by the European Centre for the Validation of Alternative Methods and the National Centre for the Replacement, Refinement and Reduction of Animals in Research. High-profile legal challenges invoking the Supreme Court and interactions with parliamentary committees have periodically prompted policy reviews and revisions to operational procedures.
Category:Animal welfare in India Category:Regulatory agencies of India